Amylyx Pharmaceuticals

United States
Primghar, Iowa, United States, 02139

Company profile

Amylyx Pharmaceuticals company profile

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain. The company features a drug designed to prevent nerve cell death and degeneration.

Business identity

Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$50,000+
Founded
2014-01-01, Year

Headquarters

Postal code
02139
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
9
Total equity funding
$595.7M
Last funding
Post IPO Equity / $175M / 2025-09-10
Last equity funding
Post IPO Equity / $175M
Investors
20
Lead investors
4
Founders
2
Articles
226
Exited on
2022-01-07

Founders and investors

Founders

Joshua CohenJustin Klee

Lead investors

ALS Finding a CureMorningsideThe ALS AssociationViking Global Investors

Investors

Alpha Wave GlobalBain Capital Life SciencesPerceptive AdvisorsRock Springs CapitalVerition Fund Management